The FDA [notified consumers and health professionals](http://www.fda.gov/medwatch/safety/2005/safety05.htm#MBI) on November 29, 2005 that MBI Distributing (also known as Molecular Biologics) has signed a [consent decree](http://www.fda.gov/bbs/topics/NEWS/2005/NEW01265.html) to stop manufacturing and distributing over-the-counter eye drops until it corrects manufacturing deficiencies found during FDA inspections.
The problem eye drops include those sold as Oxydrops, Bright Eyes, Bright Eyes II, Clarity Vision for Life, Visitein, and Can-C. The FDA found that the company lacked controls during manufacturing to ensure that the eye drops were sterile. In addition, two brands Visitein and Clarity Vision for Life are unapproved drugs.
The FDA also said that Biogesic, Bio-Ice, and Bio-Heat, over-the-counter pain-relievers sold by MBI, do not provide consumers with adequate warnings for safe use.
The FDA recommends that consumers, health care providers, and caregivers throw out any Oxydrops, Bright Eyes, Bright Eyes II, Clarity Vision for Life, Visitein, and Can-C eye drops as well as Biogesic, Bio-Ice, or Bio-Heat. They should not be used.
Adverse events resulting from the use of the eye drops or pain-relievers should be reported to the MedWatch, the FDA’s voluntary reporting program at 1-800-FDA-1088; by FAX at 1-800-FDA-0178; by mail to MedWatch, Food and Drug Administration, 5600 Fishers Lane, Rockville, MD, 20857-9787; or [online.](https://www.accessdata.fda.gov/scripts/medwatch/)
Leave a Reply
Your comments are welcome. However, specific medical advice will not be provided. Generic QUESTIONS can be directed to our Answer Line team at http://fightcolorectalcancer.org/awareness/answer-line or by calling us at 1-877-427-2111 9:00 AM – 5:00 PM Eastern time, Monday – Friday. We urge you to consult with a qualified physician for diagnosis and for answers to your personal questions. Fight Colorectal Cancer is not responsible for the medical accuracy of any comments left by persons other than Fight Colorectal Cancer staff members. Fight Colorectal Cancer staff members monitor comments and may respond publicly where appropriate.
Please note that we automatically publish the name that you enter next to your post. Also note that our pages are automatically indexed by Google and other search engines, and your name may therefore appear in search results on those sites. So if you wish to remain anonymous please use a different name or enter 'Anon' as the name.
We regret that we are unable to privately answer questions left as comments. So please do not include your phone number, email or mailing address in the body of your comment.